Apovian CM, Aronne LJ, Bessesen DH, et al
Novo Nordisk denies that a causal relationship exists between its semaglutide products and NAION and has not updated its warning labels to include vision loss as a known risk
Patients with diabetes should seek urgent medical care if they experience persistent blood glucose levels above 300 mg/dL, positive ketones in urine or blood, or symptoms of diabetic ketoacidosis (nausea, vomiting, abdominal pain) after missing doses due to medication damage
Consider Maintenance Therapy If you are not ready to stop medication entirely, some doctors may recommend switching to a lower dose or a different medication that supports long-term weight maintenance
Semaglutide is the active ingredient in Ozempic and Wegovy
AU TGA pregnancy category: D US FDA pregnancy category: Not assigned Risk summary: Limited and insufficient data are available on the use of this drug in pregnant women to inform a drug-related risk